By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Lipocine Inc. 

675 Arapeen Drive
Suite 202
Salt Lake City  Utah  84108  U.S.A.
Phone: 801-994-7383 Fax:


SEARCH JOBS








Company News
Lipocine Inc. (LPCN) Announces Positive Top-Line Results In Phase 2a Study Of LPCN 1111 10/13/2014 7:13:16 AM
Lipocine Inc. (LPCN) Testosterone Therapy Meets Phase 3 Goals 9/24/2014 7:40:52 AM
Lipocine Inc. (LPCN) To Host Conference Call And Webcast To Discuss Top-Line Results From The Phase 3 Study Of LPCN 1021 9/24/2014 7:16:25 AM
Lipocine Inc. (LPCN) Announces First Patient Dosed In Phase 1 Study In Pregnant Women Of LPCN 1107, Potentially The First Oral Product For The Prevention Of Preterm Birth 9/9/2014 7:23:31 AM
Lipocine Inc. (LPCN) Announces Financial And Operational Results For The Second Quarter Of 2014 8/13/2014 3:54:45 PM
Lipocine Inc. (LPCN) Announces Issuance Of U.S. Patent For LPCN 1021 7/16/2014 5:46:46 AM
Lipocine Inc. (LPCN) Added To Russell Microcap Index 6/30/2014 7:42:45 AM
Lipocine Inc. (LPCN) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/30/2014 9:19:20 AM
Lipocine Inc. (LPCN) Announces First Patient Dosed In Phase 2a Study Of LPCN 1111, A Novel Testosterone Ester For Oral Testosterone Replacement Therapy 5/28/2014 9:22:33 AM
Lipocine Inc. (LPCN) Announces Successful Phase 1 Results With LPCN 1107, Potentially The First Oral Product For The Prevention Of Preterm Birth 5/15/2014 11:36:07 AM
123
//-->